| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Sun protection zone is a Cypress, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biotronic NeuroNetwork is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Integrated leads the industry with Precision Empowered Care Management, enabling health plans to precisely manage their most vulnerable members. By combining actionable big data with a proven biopsychosocial model, we address the physical, psychological and social drivers impacting member health and satisfaction. As a result, plans enhance quality, achieve compliance and strengthen their financial performance, while empowering members to achieve better outcomes.
Bioexpressions is a Mill Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.